Skip to main content
Clinical Trials/CTRI/2018/01/011300
CTRI/2018/01/011300
Completed
未知

Multicatheter interstitial brachytherapy (MIBT) based accelerated partial breast irradiation (APBI) - dosimetric comparison with external beam radiotherapy and report on early outcomes in terms of toxicity and local control

ot Applicable0 sites21 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Post Surgery For Breast Cancer
Sponsor
ot Applicable
Enrollment
21
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 30, 2019
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients eligible and willing to undergo APBI. The American Society for Radiation Oncology (ASTRO) recommendations for APBI include all of the following:
  • 1\. Age \> 50 years
  • 2\. Tumor \<\= 3 cm
  • 3\. Histology: IDC Invasive Ductal Carcinoma
  • 4\. Negative Lymph node status
  • 5\. Negative resection margins
  • 6\. No evidence of Lympho\-vascular invasion
  • 7\. No evidence of Extracapsular invasion
  • 2\. In addition, patients with features considered to be cautionary by guidelines (such as ages between 40\-50 years, high grade disease, evidence of LVSI, etc.) who have been informed about the pros and cons of APBI and have voluntarily preferred undergoing the procedure will be taken up

Exclusion Criteria

  • 1\. Patients unwilling for APBI
  • 2\. Positive surgical resection margins.
  • 3\. Other definite contraindications for APBI such as multiple nodes positive, neoadjuvant chemotherapy, multifocal/multicentric disease, etc.
  • 4\. Incomplete/inadequate information on relevant Organs at Risk on Planning CT images.
  • 5\. Patients in whom the implant was deemed as unacceptable (eg: gross miss of surgical cavity).

Outcomes

Primary Outcomes

Not specified

Similar Trials